Status:
COMPLETED
BURT Efficacy in Improving Upper Extremity Strength and Function During Post-stroke Inpatient Rehabilitation
Lead Sponsor:
Sunnyview Rehabilitation Hospital
Collaborating Sponsors:
Gaylord Hospital
Conditions:
Stroke
Stroke, Acute
Eligibility:
All Genders
18-115 years
Phase:
NA
Brief Summary
The Barrett Upper Extremity Robot (BURT) is an FDA-approved upper extremity robot that assists patients with both passive and active range of motion while providing adjustable resistance (Barrett\_Med...
Eligibility Criteria
Inclusion
- Inpatient at Sunnyview Rehabilitation Hospital
- \>/= 18 years
- Unilateral stroke
- UE paresis affected arm with 3-/5 or less manual muscle testing throughout
Exclusion
- \>30 days post stroke
- Severe Neglect
- Bilateral stroke
- Prior stroke with residual deficits
- Patients receiving prism adaptation treatment
- Comorbid neurological disorders
- Upper limb comorbidities that could limit functional improvement (UE arthritis pain, UE fracture, fixed contracture not allowing for proper device alignment)
- Severe shoulder subluxation that cannot be accommodated by the device
- Severe osteoporosis
- Unable to follow simple directions
- Unable to tolerate sitting 30 minutes
- Expected length of stay (LOS) \< 15 days.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2025
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05401799
Start Date
September 1 2022
End Date
February 17 2025
Last Update
May 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaylord Hospital
Wallingford, Connecticut, United States, 06492
2
Sunnyview Rehabilitation Hospital
Schenectady, New York, United States, 12308